Novartis AG vs Yum China Holdings Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Yum China Holdings Inc trades at $43.91 (market cap $15.09B). The key difference: Novartis AG is far larger — about 19.2× Yum China Holdings Inc's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | YUMC | |
|---|---|---|
Market Cap | $290.25B | $15.09B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $57.95 |
52-Week Low | $113.50 | $40.18 |
Enterprise Value | $330.27B | $15.98B |
Dividend Yield | 3.17% | 2.64% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →